Biotia Series A: $9M

Oct 1, 2026Public sources — Collected from public sources, not yet cross-checked.

Biotia raised $9 million in a series a round, announced Oct. 1.

Facts

Company: Biotia
Amount: $9 million
Currency: USD
Stage: Series A
Announced: Oct 1, 2026
Instrument: Equity

Investors

Participants: Convergent Ventures DigitalDx Ventures Cloquet Capital Partners Continuum Health Ventures I-Lab Angels EGB Capital Leawood Venture Capital Red Bear Angels Red Bear Ventures Family office of Tim Barry Family office of Dr. Clive Fields

Use of funds

Scaling the team, expanding laboratory operations, and obtaining insurance reimbursement for assays.

As stated by the company.

Sources

1.Biotia Raises $9M to Close the Diagnostic Gap for Recurrent and Culture-Negative UTIs — AlleyWatch, Oct 2, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026